Anonymous (anonymous@undisclosed.example.com) — 2025-05-25T04:35:29+00:00

Alzheimer's Disease and Mild Cognitive Impairment Current evidence suggests ~80% of patients with Mild Cognitive Impairment (MCI) will eventually develop Alzheimer's disease (AD). Many times a trial is stated to be for Early AD which really covers both MCI and mild stage of AD. These trials involve novel approaches and new trial designs with the hope of more rapidly finding new answers for these conditions.

If you or a loved one is interested in participating in one …

ccm

Anonymous (anonymous@undisclosed.example.com) — 2024-10-14T00:40:31+00:00

Cerebral Cavernous Malformation Cavernous malformations are lesions in the brain which can grow and bleed, causing harm to the brain as a stroke, and irritability leading to seizures and epilepsy. We have no currently enrolling trials for this indication, but will update this page when a new trial becomes available.

epilepsy

Anonymous (anonymous@undisclosed.example.com) — 2024-10-14T00:41:01+00:00

Epilepsy and Seizure Disorders Condition(s) Type of Drug Phase Add-On Placebo Duration Open Label Extension Prolonged Seizures Oral Spray Alprazolam III Yes 50% 18 weeks 4 years Partial Seizures Potassium Blocker III

If you or a loved one is interested in participating in one of our trials, please contact us…

fibromyalgia

Anonymous (anonymous@undisclosed.example.com) — 2023-07-03T15:34:15+00:00

Fibromyalgia We have no currently enrolling trials for this indication, but will update this page when a new trial becomes available. Response Form

If you or a loved one is interested in participating in one of our trials, please contact us at (855) 829-88…

imaging

Anonymous (anonymous@undisclosed.example.com) — 2023-07-03T15:34:15+00:00

Imaging Studies Much of the advances in medicine in the last 20 years have been driven by new ways to look inside the body. Imaging studies do not involve treatment typically, but may require a drug to be given, especially for PET scans which involve label molecules which carry a very small amount of radiation.

If you or a loved one is interested in participating in one of our trials, please contact us at (855) 829-8899 or use the form below. One of our skille…

mig

Anonymous (anonymous@undisclosed.example.com) — 2024-04-06T21:48:40+00:00

Migraine Migraine is arguably the most common neurological condition, affecting up to 80% of adults at some time in their lives. We have no current trials enrolling for migraine, but new opportunities may be posted soon. Response Form

If you or a loved one is…

ms

Anonymous (anonymous@undisclosed.example.com) — 2024-04-06T21:50:14+00:00

Multiple Sclerosis Multiple sclerosis is a common condition of young people and mature adults, affecting nearly a million Americans. The most common form is Relapsing-Remitting, but there are also Primary Progressive, Secondary Progressive, and Progressive-Relapsing subtypes. New trials are directed against the disease itself, hoping to slow progression, or against particular symptoms like spasticity (stiffness of muscles and limbs). Response Form

If you or a loved one is interested in participating in one of our trials, please contact us at (855) 829-8899 or u…

noh

Anonymous (anonymous@undisclosed.example.com) — 2023-07-03T15:34:15+00:00

Neurogenic Orthostatic Hypotension Neurogenic Orthostatic Hypotension (NOH) is a surprisingly common condition where people become lightheaded when they stand up, with high risk for falls and injury. Few options exist for treatment, so there is need for new approaches.

If you or a loved one is interested in participating in one of our trials, please contact us at (855) 829-8899 or use the form below. One of our skilled Clinical Research Coordinators will contact you as soo…

pd

Anonymous (anonymous@undisclosed.example.com) — 2024-04-06T21:50:59+00:00

Parkinson's Disease With the advent of major organizations like the Michael J. Fox Foundation, Parkinson's research has never been busier. Current trials have focused on new symptomatic therapies and new methods of early diagnosis. Condition(s) Type of Drug Phase Add-On

start

Anonymous (anonymous@undisclosed.example.com) — 2023-07-03T15:34:15+00:00

Clinical Research at Xenoscience Enrolling in a clinical research trial can be a rewarding experience. In our view at Xenoscience and 21st Century Neurology, participation is always optional (our doctors are willing to take care of patients using conventional therapy) and voluntary (you can enter and then decide to stop participating at any time without penalty). Some trials below have a placebo, which is a 'sugar pill' or a treatment that has no effect so the trial can be unbiased and prove …

success

Anonymous (anonymous@undisclosed.example.com) — 2024-10-14T00:38:23+00:00

Our Proud History We are a clinical research site founded in 2001 by Stephen Flitman, MD, a board-certified neurologist who trained at the Barrow Neurological Institute (Phoenix, Arizona) and completed his fellowship in Cognitive Neuroscience at the prestigious National Institutes of Health (Bethesda, Maryland). He served as first Associate Director then Director of Cognitive Neurology Section at Barrow until 2001.

tn

Anonymous (anonymous@undisclosed.example.com) — 2023-07-03T15:34:15+00:00

Trigeminal Neuralgia We have no currently enrolling trials for this indication, but will update this page when a new trial becomes available. Response Form

If you or a loved one is interested in participating in one of our trials, please contact us at (855) …

Neurozone

ad

ccm

epilepsy

fibromyalgia

imaging

mig

ms

noh

pd

start

success

tn